Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Description Epithalon is a synthetic tetrapeptide supplied as a lyophilized research material for in vitro and analytical laboratory applications
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Other Peptides: What Sets It Apart
From Pubchem IUPAC Name: (4S)-4-[[(2S)-2-aminopropanoyl] amino]-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl] amino]-5-oxopentanoic acid Synonyms: Epithalone, alanyl-glutamyl-aspartyl-glycine, epitalon, epithalon Molecular Formula: C14H22N4O9 Molecular Weight: 390.35 g/mol Sequence: Ala-Glu-Asp-Gly CAS number: 307297-39-8 PubChem CID: 219042 Epithalon was initially researched and developed in Russia by Dr
Understanding the right way to approach their use in a lab setting is the first, critical step
Slower gastric emptying also means timing and meal size matter, and we coach patients through both
